Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020

Clinical trial NCT02068053 · COMPLETED

Trial details

NCT number: NCT02068053
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immunosuppression For Disease

Start date: 2014-03-01
Primary completion: 2014-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.